title: Ubiquitin-specific protease 22: a novel molecular biomarker in cervical cancer prognosis and therapeutics.
abstract: Ubiquitin-specific protease 22 (USP22) exhibits an important function in tumor progression and oncogenesis. The aim of this study was to investigate the role of USP22 and the association with its potential targets in patients with cervical cancer. To our knowledge, this is the first study that determines the relationship between USP22 expression and clinicopathological significance in cervical cancer. The immunohistochemistry results showed that USP22 protein was overexpressed in cervical cancer samples compared with normal cervical tissues (P < 0.001). Moreover, clinicopathological analysis showed that USP22 expression was highly related to International Federation of Gynecology and Obstetrics stage, Ki67, lymph node metastasis, and histology grade. The results of Kaplan-Meier analysis indicated that patients with high USP22 expression had significantly shorter overall survival (OS) and disease-free survival (DFS) than patients with low expression of USP22 (P < 0.001). Multivariate Cox regression analysis revealed that USP22 expression status was an independent prognostic marker for both OS and DFS of patients with cervical cancer. It is suggested that USP22 overexpression may be associated with poor prognosis in cervical cancer. It may represent a novel prognostic biomarker or a target for improving the treatment efficiency of patients with cervical cancer.
authors: Department of Gynecology, The Third Affiliated (Tumor) Hospital, Harbin Medical University, Harbin, 150081, China.
authors: Meng
authors: M
authors: Yang
authors: Yun-Duo
authors: YD
authors: Liu
authors: Yan-Ying
authors: YY
authors: Wang
authors: Tian-Bo
authors: TB
authors: Liu
authors: Ting-Ting
authors: TT
authors: Ge
authors: Ge
authors: G
authors: Lou
mesh_terms: D000328:Adult; D000368:Aged; D014408:Biomarkers, Tumor / Q000235:genetics*; D018572:Disease-Free Survival; D005260:Female; D015972:Gene Expression Regulation, Neoplastic; D006801:Humans; D008207:Lymphatic Metastasis / Q000235:genetics* / Q000473:pathology; D008875:Middle Aged; D009367:Neoplasm Staging; D011247:Pregnancy; D011379:Prognosis; D013869:Thiolester Hydrolases / Q000235:genetics* / Q000378:metabolism; D016896:Treatment Outcome; D043222:Ubiquitin Thiolesterase; D002583:Uterine Cervical Neoplasms / Q000188:drug therapy / Q000235:genetics* / Q000473:pathology
chemical_list: D014408:Biomarkers, Tumor; D013869:Thiolester Hydrolases; D043222:Ubiquitin Thiolesterase; C527170:Usp22 protein, human
references: J Gastroenterol Hepatol. 2010 Nov;25(11):1800-5
references: 21039844
references: EMBO Rep. 2011 Sep 01;12(9):924-30
references: 21779003
references: Mol Cell. 2008 Jan 18;29(1):102-11
references: 18206973
references: CA Cancer J Clin. 2007 Jan-Feb;57(1):7-28
references: 17237032
references: J Cancer Res Clin Oncol. 2011 Aug;137(8):1245-53
references: 21691749
references: Nature. 2009 Mar 26;458(7237):438-44
references: 19325623
references: Histopathology. 2012 May;60(6):953-63
references: 22372608
references: Cell Cycle. 2008 Jun 1;7(11):1522-4
references: 18469533
references: CA Cancer J Clin. 2013 Jan;63(1):11-30
references: 23335087
references: Int J Biol Macromol. 2012 Dec;51(5):788-93
references: 22829051
references: CA Cancer J Clin. 2011 Jul-Aug;61(4):212-36
references: 21685461
references: Tumour Biol. 2012 Oct;33(5):1653-9
references: 22648564
references: Genes Dev. 2001 Aug 15;15(16):2042-7
references: 11511535
references: Cell Biochem Biophys. 2012 Jan;62(1):229-35
references: 21928107
references: Mol Cell. 2008 Feb 1;29(2):152-4
references: 18243109
references: Mol Cell Biochem. 2011 Jan;346(1-2):11-21
references: 20824490
references: Gene Expr Patterns. 2006 Mar;6(3):277-84
references: 16378762
references: Nat Rev Cancer. 2004 Feb;4(2):143-53
references: 14732866
references: Int J Biol Macromol. 2013 Feb;53:72-6
references: 23164756
references: Carbohydr Polym. 2012 Nov 6;90(4):1671-6
references: 22944432
references: Tumour Biol. 2013 Dec;34(6):3939-44
references: 23838802
references: Tumour Biol. 2014 Jan;35(1):55-60
references: 23873101
references: Tumour Biol. 2012 Oct;33(5):1275-8
references: 22664949
references: Cell. 2007 Feb 23;128(4):683-92
references: 17320506
references: N Engl J Med. 2003 Feb 6;348(6):518-27
references: 12571259
references: Carbohydr Polym. 2012 Oct 1;90(2):1127-31
references: 22840049
references: Int J Biol Macromol. 2012 Dec;51(5):968-73
references: 22750577
references: Obstet Gynecol. 1992 May;79(5 ( Pt 1)):675-82
references: 1314359
references: Cell Cycle. 2006 Jun;5(11):1208-16
references: 16760651
references: Gynecol Oncol. 2008 Sep;110(3 Suppl 2):S4-7
references: 18760711
references: CA Cancer J Clin. 2005 Mar-Apr;55(2):74-108
references: 15761078
references: Carbohydr Polym. 2013 Feb 15;92(2):2212-7
references: 23399279
references: Int J Colorectal Dis. 2010 Oct;25(10):1201-9
references: 20625905
references: Mol Cell. 2008 Jan 18;29(1):92-101
references: 18206972
references: BMJ. 1999 Aug 21;319(7208):505-8
references: 10454408
references: FASEB J. 2012 Feb;26(2):842-54
references: 22067483
references: J Surg Oncol. 2011 Mar 1;103(3):283-9
references: 21337558
references: Int J Biol Macromol. 2013 Jun;57:22-5
references: 23500436
references: J Clin Oncol. 2008 Jun 10;26(17):2846-53
references: 18539963